Lupin Limited
LUPIN.NS
₹2069.20
▼ 1.47%
Lupin was among the day's pharma laggards, down 1.47% to ₹2,069.20 with no specific news cited for the fall. The stock's returns have been choppy of late — up 4.57% over one year but down 3.49% over two years — even as the five-year CAGR of 16.07% points to healthier underlying momentum. Analyst sentiment is more measured here, with a consensus hold rating from 36 analysts and an average target of ₹2,490.58.
CAGR Performance
| 1 Year | 2 Years | 5 Years | 10 Years |
|---|---|---|---|
| 4.96% | -3.31% | 16.16% | 3.08% |
Analyst Consensus
Average Target Price: ₹2490.58 (range ₹1800.00 - ₹3095.00) based on 36 analysts
Strong Buy: 9
Buy: 8
Hold: 10
Sell: 6
Strong Sell: 3
No comments:
Post a Comment